Revenue Summary of Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited's latest annual revenue in 2023 was 26.19 Billion CNY , down -8.97% from previous year.
Sino Biopharmaceutical Limited's latest quarterly revenue in 2024 Q1 was 7.93 Billion CNY , down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported a annual revenue of 28.78 Billion CNY in annual revenue 2022, up 7.14% from previous year.
Sino Biopharmaceutical Limited reported a annual revenue of 26.86 Billion CNY in annual revenue 2021, up 13.59% from previous year.
Sino Biopharmaceutical Limited reported a quarterly revenue of 7.93 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported a quarterly revenue of 7.63 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Revenue of Sino Biopharmaceutical Limited (2023 - 1999)

Year	Revenue	Revenue Growth
2023	26.19 Billion CNY	-8.97%
2022	28.78 Billion CNY	7.14%
2021	26.86 Billion CNY	13.59%
2020	23.64 Billion CNY	-2.42%
2019	24.23 Billion CNY	16.02%
2018	20.88 Billion CNY	40.96%
2017	14.81 Billion CNY	4.58%
2016	14.17 Billion CNY	16.3%
2015	12.18 Billion CNY	23.09%
2014	9.89 Billion CNY	27.94%
2013	7.73 Billion CNY	15.4%
2012	6.7 Billion CNY	43.27%
2011	4.67 Billion CNY	34.39%
2010	3.48 Billion CNY	21.94%
2009	2.85 Billion CNY	42.12%
2008	2 Billion CNY	84.24%
2007	1.09 Billion CNY	48.06%
2006	736.63 Million CNY	-6.4%
2005	787.02 Million CNY	-29.67%
2004	1.11 Billion CNY	27.73%
2003	876.11 Million CNY	19.24%
2002	734.72 Million CNY	28.23%
2001	572.97 Million CNY	37.46%
2000	416.84 Million CNY	28.06%
1999	325.51 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	7.93 Billion CNY	0.0%
2024 Q2	7.93 Billion CNY	0.0%
2023 Q2	7.63 Billion CNY	0.0%
2023 Q1	7.63 Billion CNY	89.11%
2023 Q3	- HKD	-100.0%
2023 FY	26.19 Billion CNY	-8.97%
2022 Q3	6.79 Billion CNY	-10.58%
2022 Q2	7.59 Billion CNY	0.0%
2022 Q1	7.59 Billion CNY	21.48%
2022 FY	28.78 Billion CNY	7.14%
2022 Q4	4.03 Billion CNY	-40.54%
2021 Q2	7.11 Billion CNY	-1.83%
2021 Q3	6.25 Billion CNY	-12.05%
2021 Q4	6.25 Billion CNY	0.0%
2021 FY	26.86 Billion CNY	13.59%
2021 Q1	7.24 Billion CNY	31.18%
2020 Q4	5.52 Billion CNY	0.79%
2020 Q2	6.42 Billion CNY	3.28%
2020 FY	23.64 Billion CNY	-2.42%
2020 Q1	6.22 Billion CNY	26.63%
2020 Q3	5.47 Billion CNY	-14.75%
2019 Q4	4.91 Billion CNY	-27.68%
2019 FY	24.23 Billion CNY	16.02%
2019 Q1	6.2 Billion CNY	20.35%
2019 Q3	6.79 Billion CNY	7.5%
2019 Q2	6.31 Billion CNY	1.79%
2018 Q4	5.15 Billion CNY	-14.1%
2018 FY	20.88 Billion CNY	40.96%
2018 Q1	4.65 Billion CNY	37.95%
2018 Q2	5.07 Billion CNY	9.03%
2018 Q3	6 Billion CNY	18.38%
2017 Q4	3.37 Billion CNY	-14.92%
2017 Q3	3.96 Billion CNY	9.51%
2017 Q2	3.61 Billion CNY	-6.3%
2017 FY	14.81 Billion CNY	4.58%
2017 Q1	3.86 Billion CNY	8.24%
2016 Q4	3.56 Billion CNY	-4.15%
2016 Q1	3.47 Billion CNY	24.66%
2016 FY	14.17 Billion CNY	16.3%
2016 Q2	3.4 Billion CNY	-2.12%
2016 Q3	3.72 Billion CNY	9.47%
2015 Q4	2.78 Billion CNY	-18.79%
2015 Q1	2.98 Billion CNY	12.88%
2015 Q3	3.43 Billion CNY	15.45%
2015 FY	12.18 Billion CNY	23.09%
2015 Q2	2.97 Billion CNY	-0.53%
2014 Q1	2.33 Billion CNY	24.32%
2014 Q4	2.64 Billion CNY	5.73%
2014 Q3	2.5 Billion CNY	3.79%
2014 Q2	2.41 Billion CNY	3.48%
2014 FY	9.89 Billion CNY	27.94%
2013 Q4	1.87 Billion CNY	-10.02%
2013 FY	7.73 Billion CNY	15.4%
2013 Q1	1.83 Billion CNY	5.56%
2013 Q2	1.93 Billion CNY	5.55%
2013 Q3	2.08 Billion CNY	7.5%
2012 FY	6.7 Billion CNY	43.27%
2012 Q4	1.74 Billion CNY	-0.51%
2012 Q3	1.74 Billion CNY	-0.58%
2012 Q1	1.45 Billion CNY	31.01%
2012 Q2	1.75 Billion CNY	20.91%
2011 Q1	1.04 Billion CNY	0.0%
2011 Q2	1.2 Billion CNY	15.55%
2011 Q3	1.31 Billion CNY	9.24%
2011 Q4	1.11 Billion CNY	-15.73%
2011 FY	4.67 Billion CNY	34.39%
2010 Q1	799.64 Million CNY	0.0%
2010 Q2	886.75 Million CNY	10.89%
2010 FY	3.48 Billion CNY	21.94%
2009 FY	2.85 Billion CNY	42.12%
2008 FY	2 Billion CNY	84.24%
2007 FY	1.09 Billion CNY	48.06%
2006 FY	736.63 Million CNY	-6.4%
2005 FY	787.02 Million CNY	-29.67%
2004 FY	1.11 Billion CNY	27.73%
2003 FY	876.11 Million CNY	19.24%
2002 FY	734.72 Million CNY	28.23%
2001 FY	572.97 Million CNY	37.46%
2000 FY	416.84 Million CNY	28.06%
1999 FY	325.51 Million CNY	0.0%

Peer Revenue Comparison of Sino Biopharmaceutical Limited

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-5305.083%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	-392.217%

Global Stocks Search

Sino Biopharmaceutical Limited (1177.HK)

Revenue Summary of Sino Biopharmaceutical Limited

Annual Revenue Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Revenue of Sino Biopharmaceutical Limited (2023 - 1999)

Peer Revenue Comparison of Sino Biopharmaceutical Limited